Small cell lung cancer in a 14-year-old girl.
Pediatric lung cancer is uncommon, and small cell lung cancer (SCLC) is exceptionally rare. A 14-year-old previously healthy girl was diagnosed with limited-stage SCLC, which was considered inoperable. She responded well to chemotherapy with carboplatin and etoposide, and surgical resection was performed after 2 cycles. High-dose thoracic radiotherapy in combination with etoposide and carboplatin was given as postoperative treatment. The patient died of relapsing disease 21 months after initial diagnosis. Only 1 single case report on SCLC has been published earlier. Additional reports on pediatric SCLC are needed to evaluate appropriate treatment.
Department of Pediatrics, Haukeland University Hospital, Bergen, Norway. havard.tronnes@isf.uib.no
Håvard
H
Trønnes
Hans Kristian
HK
Haugland
Albert N
AN
Békássy
Svein Inge
SI
Helle
Halfdan
H
Sorbye
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy*; D011013:Pneumonectomy; D011878:Radiotherapy; D055752:Small Cell Lung Carcinoma / Q000473:pathology* / Q000628:therapy*